mobile Health research

Data quality at academic standard

We are engaged in research in collaboration with cancer research centers, hospitals and the life science sector. The data collected from patients in combination with clinical data opens up new opportunities for research. 

More than 1500 patients are already enrolled in our studies.

This will enable the development of new, targeted methods for the treatment of cancer and chronic diseases.

MobileHealth-Network-Parts_Patient

As a patient

You support cancer research by sharing your data in the app in anonymized form. In this way, you contribute to improving treatment with your patient experience – voluntarily, of course.

MobileHealth-Network-Parts-Arzt

As a physician

You support cancer research by helping patients use the app and participating in studies and registries.

MobileHealth-Network-Parts-Hospital

Co-Creation

Initiating new research approaches together – you have an idea? We have the necessary tools, contacts and experience-

Ongoing studies

HER2-directed Biosimilar OgivriTM in Breast Cancer: Real world Observational trial for the description of Quality of Life and Outcome using ePRO
Oral Medicinal Cannabis (CBD:THC) as Add-On to Standard of Care for Symptomatic and Palliative Treatment in Cancer Patients
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR-T Immunotherapy
The possible influence of different follow-up strategies on overall survival in ovarian cancer: a multicenter observational study
Alpine Tumor Immunology Registry
Evaluation of the consilium care™ digital health application in patients with HER2- positive breast cancer during chemotherapy in combination with HER2-targeted antibody therapy: a multicenter randomized controlled trial.

Research & publications

Trojan A, et al:

The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicentre, Observational Clinical Trial.

JMIR 2021;23(8):e29271.

Trojan A, et al.:

Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study.

​JMIR Cancer. 2021 Mar 17,7(1): e26950

Trojan A, et al.:

Consilium smartphone app for real-world electronically captured patient-reported outcome monitoring in cancer patients undergoing anti-PD-L1-directed treatment.

Case Rep Oncol 2020;13:491–496

Egbring M, et al.:

A mobile app to stabilize daily functional activity of breast cancer patients in collaboration with the physician: A randomized controlled clinical trial.

JMIR 2016; 18(9): e238.

Pircher M, et al.:

Response to Vemurafenib in metastatic triple negative breast cancer harbouring a BRAF V600E mutation: a case report and electronically captured patient reported outcome (ePROs).

Case Rep Oncol 2021;14:616–621. ​

Prof. Dr. med. Andreas Trojan

CEO, Chief Medical Officer, Founder

Team and expertise

Products developed by qualified experts

Andreas holds a position as senior oncologist at both, the Brust- and the OnkoZentrum Zürich in Switzerland. Moreover, he is a titular-professor at the medical faculty of the University of Zurich. Treating cancer patients over more than 20 years clearly indicated that the consideration of PROs is key for treatment success. Driven by this conviction Andreas founded Mobile Health AG and started to develop Consilium Care™, an App for patients to capture well-being and therapy side effects. The current large observational study, started in 2018, investigates the efficiency of the “Consilium Care™” smartphone App for detecting symptoms and treatment side effects in cancer patients depending on form of medication application, age and outpatient characteristics.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Prof. Dr. med. Andreas Trojan

Individual patient

Doctor

Consilium Care™ platform

1. Patients track their health with Consilium Care™

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

3. Treatment plans can be adjusted due to insights

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

Mobile Health

Evidence-based care in the real-world

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.